The two companies were working together on DNA sequencing technology, but the pharmaceutical giant pulled out Tuesday.
Amgen, Celgene and Pharmacyclics see short interest drop recently.
There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.
SunPower is initiated with an 'outperform,' and Deutsche Bank is downgraded to 'sell.'
Earnings issues linger in every sector and guidance disappoints.
Under Armour is upgraded to 'outperform,' and First Solar is downgraded to 'underperform.'
Speculators can buy a biotech stock while the more conservative should consider a biotech fund.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
All hail the bull market, which ended the week with a big rally. But it also is starting to look a little like 1987, which suffered an epic blow-out.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.